These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12589151)

  • 1. Bone disease after renal transplantation.
    Heaf JG
    Transplantation; 2003 Feb; 75(3):315-25. PubMed ID: 12589151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone complications of renal transplantation. How to identify and prevent them].
    Messa P; Aroldi A; Villa M; Rusconi E
    G Ital Nefrol; 2004; 21(4):331-42. PubMed ID: 15470659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone disease after renal transplantation.
    Weisinger JR; Carlini RG; Rojas E; Bellorin-Font E
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1300-13. PubMed ID: 17699362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis of secondary hyperparathyroidism and renal bone disease].
    Ito H; Kinugasa E
    Clin Calcium; 2004 May; 14(5):720-5. PubMed ID: 15577032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperparathyroidism and vitamin D deficiency predispose to bone loss in renal transplant recipients.
    Lim WH; Coates PS; Russ GR; Coates PT
    Transplantation; 2009 Sep; 88(5):678-83. PubMed ID: 19741465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and management of bone disease and fractures post transplant.
    Bia M
    Transplant Rev (Orlando); 2008 Jan; 22(1):52-61. PubMed ID: 18631858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation.
    Al-Gabri S; Zadrazil J; Krejcí K; Horák P; Bachleda P
    Transplant Proc; 2005 Mar; 37(2):1014-9. PubMed ID: 15848609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
    Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E
    Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parathyroid and bone. Secondary hyperparathyroidism after renal transplantation].
    Negi S; Okamoto M; Shigematsu T
    Clin Calcium; 2007 Dec; 17(12):1880-7. PubMed ID: 18057664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue.
    Toussaint ND; Elder GJ; Kerr PG
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):221-33. PubMed ID: 18987295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: Managing bone complications after kidney transplantation.
    Mainra R; Elder G
    Nephrology (Carlton); 2009 Jun; 14(4):437-42. PubMed ID: 19563386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-dihydroxyvitamin D(3) therapy is protective for renal function and prevents hyperparathyroidism in renal allograft recipients.
    Uyar M; Sezer S; Arat Z; Elsurer R; Ozdemir FN; Haberal M
    Transplant Proc; 2006 Sep; 38(7):2069-73. PubMed ID: 16980002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What should we call it: renal rickets, renal osteodystrophy or renal osteopathy?].
    De Toni G
    Minerva Med; 1972 Aug; 63(57):3102-6. PubMed ID: 5054007
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
    Brown AJ; Slatopolsky E
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):134-44. PubMed ID: 17237840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal osteodystrophy.
    McCarthy JT; Kumar R
    Endocrinol Metab Clin North Am; 1990 Mar; 19(1):65-93. PubMed ID: 2192869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of subtotal vs total parathyroidectomy without autotransplantation in kidney transplant recipients.
    Rayes N; Seehofer D; Schindler R; Reinke P; Kahl A; Ulrich F; Neuhaus P; Nüssler NC
    Arch Surg; 2008 Aug; 143(8):756-61; discussion 761. PubMed ID: 18711035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.
    Walsh SB; Altmann P; Pattison J; Wilkie M; Yaqoob MM; Dudley C; Cockwell P; Sweny P; Banks LM; Hall-Craggs M; Noonan K; Andrews C; Cunningham J
    Am J Kidney Dis; 2009 May; 53(5):856-65. PubMed ID: 19393473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
    Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
    Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.